However, the protective effect of PPARα against obesity and NAFLD has been demonstrated in both human and animal studies, effects that were attributed to their hypolipidemic, hypoglycemic, and anti-inflammatory effects, as well as their ability to improve insulin sensitivity [10,11,15,16,17,18,19]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.